SpaceOAR® hydrogel is a prostate rectum spacer that separates and protects the rectum during prostate radiotherapy. The hydrogel spacer provides a barrier between the prostate and rectum to decrease rectal toxicity and minimize changes in quality of life (QOL) following prostate radiotherapy. The 3-year follow-up study results of a Phase 3 clinical trial demonstrated a significant reduction in late rectal toxicity (78%) along with favorable bowel, urinary and sexual QOL measurements. SpaceOAR hydrogel is placed via a transperineal injection, the procedure can be performed in an in-office setting under local anesthesia and is reimbursed under CPT® code 55874. SpaceOAR System is FDA cleared, CE marked, approved in Australia and Japan and licensed in Canada.
By requesting information, you agree to share the email you provided at the time of registration with the exhibitor for follow-up. Click on “Submit” to share your email or “Cancel” to cancel your information request.